The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

The age range for HSIIDC Group B positions is 18–42 years. Age relaxation will be granted in accordance with the Haryana ...

A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Jade Biosciences, Inc. ( JBIO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 2:15 PM EST ...

GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Life Extension reports women live 5.4 years longer than men due to biological and behavioral factors, but men can narrow this gap with lifestyle changes.